{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:19:16Z","timestamp":1794673156411,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T00:00:00Z","timestamp":1717718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.xcrm.2024.101627","type":"journal-article","created":{"date-parts":[[2024,7,3]],"date-time":"2024-07-03T11:26:48Z","timestamp":1720006008000},"page":"101627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer"],"prefix":"10.1016","volume":"5","author":[{"given":"Yi","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shangru","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lefan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingle","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yubin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry Cheuk-Hay","family":"Lau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Jao-Yiu","family":"Sung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixia","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5008-2153","authenticated-orcid":false,"given":"Jun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2024.101627_bib1","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185\u00a0Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA. Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2024.101627_bib2","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2024.101627_bib3","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.annonc.2022.07.004","article-title":"Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Lordick","year":"2022","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2024.101627_bib4","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1200\/JCO.18.01138","article-title":"Addition of Docetaxel to Oral Fluoropyrimidine Improves Efficacy in Patients With Stage III Gastric Cancer: Interim Analysis of JACCRO GC-07, a Randomized Controlled Trial","volume":"37","author":"Yoshida","year":"2019","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2024.101627_bib5","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.2010.534","article-title":"Benefit of adjuvant chemotherapy for resectable gastric cancer: a meta-analysis","volume":"303","author":"Paoletti","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.xcrm.2024.101627_bib6","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S1470-2045(20)30315-6","article-title":"S-1 plus leucovorin and oxaliplatin versus S-1 plus cisplatin as first-line therapy in patients with advanced gastric cancer (SOLAR): a randomised, open-label, phase 3 trial","volume":"21","author":"Kang","year":"2020","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2024.101627_bib7","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1016\/S0140-6736(18)32557-1","volume":"393","author":"Al-Batran","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2024.101627_bib8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1126\/science.aao2774","article-title":"Patient-derived organoids model treatment response of metastatic gastrointestinal cancers","volume":"359","author":"Vlachogiannis","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2024.101627_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2019.10.010","article-title":"Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer","volume":"26","author":"Yao","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2024.101627_bib10","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/nrm3873","article-title":"Three-dimensional organotypic culture: experimental models of mammalian biology and disease","volume":"15","author":"Shamir","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.xcrm.2024.101627_bib11","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.stem.2018.09.016","article-title":"A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening","volume":"23","author":"Yan","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.xcrm.2024.101627_bib12","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/gutjnl-2017-314549","article-title":"Human gastric cancer modelling using organoids","volume":"68","author":"Seidlitz","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2024.101627_bib13","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jcmgh.2018.09.008","article-title":"An Organoid-Based Preclinical Model of Human Gastric Cancer","volume":"7","author":"Steele","year":"2019","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2024.101627_bib14","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1158\/2159-8290.CD-18-0349","article-title":"Organoid Profiling Identifies Common Responders to Chemotherapy in Pancreatic Cancer","volume":"8","author":"Tiriac","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101627_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14262","article-title":"Molecular dissection of colorectal cancer in pre-clinical models identifies biomarkers predicting sensitivity to EGFR inhibitors","volume":"8","author":"Sch\u00fctte","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101627_bib16","doi-asserted-by":"crossref","first-page":"4840","DOI":"10.1038\/s41467-021-25122-4","article-title":"Predictive biomarkers for 5-fluorouracil and oxaliplatin-based chemotherapy in gastric cancers via profiling of patient-derived xenografts","volume":"12","author":"Na","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101627_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103023","article-title":"Clinically applicable 53-Gene prognostic assay predicts chemotherapy benefit in gastric cancer: A multicenter study","volume":"61","author":"Zhu","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.xcrm.2024.101627_bib18","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41467-022-28437-y","article-title":"Development and validation of a prognostic and predictive 32-gene signature for gastric cancer","volume":"13","author":"Cheong","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2024.101627_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","article-title":"First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase\u00a03 trial","volume":"398","author":"Janjigian","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2024.101627_bib20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.neo.2019.05.002","article-title":"Notch and mTOR Signaling Pathways Promote Human Gastric Cancer Cell Proliferation","volume":"21","author":"Hibdon","year":"2019","journal-title":"Neoplasia"},{"key":"10.1016\/j.xcrm.2024.101627_bib21","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1158\/2159-8290.CD-23-0050","article-title":"Colorectal Cancer Organoid-Stroma Biobank Allows Subtype-Specific Assessment of Individualized Therapy Responses","volume":"13","author":"Farin","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2024.101627_bib22","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/path.5675","article-title":"Modelling hereditary diffuse gastric cancer initiation using transgenic mouse-derived gastric organoids and single-cell sequencing","volume":"254","author":"Dixon","year":"2021","journal-title":"J.\u00a0Pathol."},{"key":"10.1016\/j.xcrm.2024.101627_bib23","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/cdd.2012.30","article-title":"TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the LC3-interacting region (LIR) and promotes autophagy-dependent cell death","volume":"19","author":"Seillier","year":"2012","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.xcrm.2024.101627_bib24","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1016\/j.ejca.2012.12.017","article-title":"miR-17-5p\/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation","volume":"49","author":"Wang","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xcrm.2024.101627_bib25","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1073\/pnas.1108411109","article-title":"Brush border myosin Ia has tumor suppressor activity in the intestine","volume":"109","author":"Mazzolini","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2024.101627_bib26","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1002\/ijc.27856","article-title":"Brush border myosin Ia inactivation in gastric but not endometrial tumors","volume":"132","author":"Mazzolini","year":"2013","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2024.101627_bib27","first-page":"8880","article-title":"Deleted in Malignant Brain Tumors 1 is a versatile mucin-like molecule likely to play a differential role in digestive tract cancer","volume":"61","author":"Mollenhauer","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101627_bib28","first-page":"473","article-title":"Evaluation of CSTB and DMBT1 expression in saliva of gastric cancer patients and controls","volume":"22","author":"Koopaie","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2024.101627_bib29","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/gutjnl-2014-308416","article-title":"Gastric tumour-derived ANGPT2 regulation by DARPP-32 promotes angiogenesis","volume":"65","author":"Chen","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.xcrm.2024.101627_bib30","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1053\/j.gastro.2011.06.070","article-title":"DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib","volume":"141","author":"Zhu","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2024.101627_bib31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1756-8722-6-43","article-title":"L1cam promotes tumor progression and metastasis and is\u00a0an independent unfavorable prognostic factor in gastric cancer","volume":"6","author":"Chen","year":"2013","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.xcrm.2024.101627_bib32","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13046-021-01848-3","article-title":"Overexpression of NELFE contributes to gastric cancer progression via Wnt\/\u03b2-catenin signaling-mediated activation of CSNK2B expression","volume":"40","author":"Yu","year":"2021","journal-title":"J.\u00a0Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2024.101627_bib33","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/j.gastro.2022.06.021","article-title":"Dysplastic Stem Cell Plasticity Functions as a Driving Force for Neoplastic Transformation of Precancerous Gastric Mucosa","volume":"163","author":"Min","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.xcrm.2024.101627_bib34","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/JTO.0b013e3181ec173d","article-title":"Receiver operating characteristic curve in diagnostic test assessment","volume":"5","author":"Mandrekar","year":"2010","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.xcrm.2024.101627_bib35","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1158\/2326-6066.CIR-19-0311","article-title":"Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer","volume":"7","author":"Jiang","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2024.101627_bib36","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jcmgh.2020.09.003","article-title":"Cancer-Associated Fibroblasts Provide a Stromal Niche for Liver Cancer Organoids That Confers Trophic Effects and Therapy Resistance","volume":"11","author":"Liu","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.xcrm.2024.101627_bib37","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","article-title":"Generation of Tumor-Reactive T Cells by Co-culture of Peripheral Blood Lymphocytes and Tumor Organoids","volume":"174","author":"Dijkstra","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101627_bib38","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1038\/s41591-019-0584-2","article-title":"A rectal cancer organoid platform to study individual responses to chemoradiation","volume":"25","author":"Ganesh","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2024.101627_bib39","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.cell.2015.03.053","article-title":"Prospective derivation of a living organoid biobank of colorectal cancer patients","volume":"161","author":"van de Wetering","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2024.101627_bib40","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","article-title":"Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation","volume":"173","author":"Malta","year":"2018","journal-title":"Cell"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124003318?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379124003318?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T04:15:40Z","timestamp":1722140140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379124003318"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2666379124003318"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101627","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalized drug screening using patient-derived organoid and its clinical relevance in gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2024.101627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101627"}}